Marker Therapeutics (NASDAQ:MRKR – Get Rating) and Acerus Pharmaceuticals (OTCMKTS:ASPCF – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, profitability, earnings and analyst recommendations. Analyst Recommendations This is a breakdown of current ratings […]
Acerus Pharmaceuticals (OTCMKTS:ASPCF – Get Rating) and Marker Therapeutics (NASDAQ:MRKR – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, valuation, dividends, profitability, earnings and institutional ownership. Volatility & Risk Acerus Pharmaceuticals has a beta of […]
Acerus Pharmaceuticals (OTCMKTS:ASPCF – Get Rating) and Ovid Therapeutics (NASDAQ:OVID – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, earnings, profitability, valuation and dividends. Analyst Ratings This is a breakdown of current ratings […]